EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Synergistic effect of combinational SHEN26 and PF07817883 in SARS-CoV-2 infection

Jiacheng Huang, Yujian Yang, Tiefeng Xu, Jianwei Liang, Xin Wang, Guanguan Li, Lihong Liu, Keda Shi, Zhao Lv, Xikui Sun, Chunmei Li, Xumu Zhang und 3 weitere

Virologica Sinica · 2026-10 · 41 (5) · 1261-1264

DOI: 10.1016/j.virs.2026.09.006 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Virologica Sinica, 2026-10. Verfasst von Jiacheng Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China; Institute of Human Virology, Department of Pathogen Biolo…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Major Science and Technology Projects of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• ATV014 (SHEN26) and PF07817883 exhibited potent synergistic antiviral activity against SARS-CoV-2 in vitro. • In vivo, the combination showed synergistic antiviral and tissue-repair effects superior to either monotherapy. • The therapeutic potential of combining a RdRp inhibitor with a main protease inhibitor as a complementary antiviral strategy.

Autor:innen und Institutionen

  • Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China; Institute of Human Virology, Department of Pathogen Biology and Biosecurity, And Key Laboratory of Tropical Disease Control of…
  • Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Department of Chemistry, College of Science, Academy for Advanced Interdisciplinary Studies and Medi-X Pingshan, Southern University of Science and…
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou 510005, China.
  • Shenzhen AntiV Pharma Co. Ltd., Shenzhen 518118, China.
  • MOE Key Laboratory of Tropical Disease Control, Zhongshan School of Medicine, Sun Yat-sen University Shenzhen Campus, Sun Yat-Sen University, Shenzhen 518107, China.

Förderung

  • National Major Science and Technology Projects of China

Zitieren

APA

Huang, J., Yang, Y., Xu, T., Liang, J., Wang, X., Li, G., Liu, L., Shi, K., Lv, Z., Sun, X., Li, C., Zhang, X., Zhou, Q., Yang, S., & Guo, D. (2026). Synergistic effect of combinational SHEN26 and PF07817883 in SARS-CoV-2 infection. Virologica Sinica, 41(5), 1261-1264. https://doi.org/10.1016/j.virs.2026.09.006

Vancouver

Huang J, Yang Y, Xu T, Liang J, Wang X, Li G, et al. Synergistic effect of combinational SHEN26 and PF07817883 in SARS-CoV-2 infection. Virologica Sinica. 2026;41(5):1261-1264. doi:10.1016/j.virs.2026.09.006

BibTeX
@article{Huang2026,
  author = {Huang, Jiacheng and Yang, Yujian and Xu, Tiefeng and Liang, Jianwei and Wang, Xin and Li, Guanguan and Liu, Lihong and Shi, Keda and Lv, Zhao and Sun, Xikui and Li, Chunmei and Zhang, Xumu and Zhou, Qifan and Yang, Sidi and Guo, Deyin},
  title = {Synergistic effect of combinational SHEN26 and PF07817883 in SARS-CoV-2 infection},
  journal = {Virologica Sinica},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {1261--1264},
  doi = {10.1016/j.virs.2026.09.006}
}
Kostenlos starten →